| US 7,507,826 B2 | ||
| Azaindoles useful as inhibitors of JAK and other protein kinases | ||
| Francesco Salituro, Marlborough, Mass. (US); Luc Farmer, Foxboro, Mass. (US); Randy Bethiel, Lexington, Mass. (US); Edmund Harrington, Plymouth, Mass. (US); Jeremy Green, Waltham, Mass. (US); John Court, Littleton, Mass. (US); Jon Come, Cambridge, Mass. (US); David Lauffer, Stow, Mass. (US); Alex Aronov, Watertown, Mass. (US); Hayley Binch, San Diego, Calif. (US); Dean Boyall, Abingdon (United Kingdom); Jean-Damien Charrier, Wantage (United Kingdom); Simon Everitt, Beaconsfields (United Kingdom); Damien Fraysse, Abingdon (United Kingdom); Michael Mortimore, Burford (United Kingdom); Francoise Pierard, Abingdon (United Kingdom); Daniel Robinson, Abingdon (United Kingdom); Jian Wang, Newton, Mass. (US); Joanne Pinder, Abingdon (United Kingdom); Tiansheng Wang, Concord, Mass. (US); and Albert Pierce, Cambridge, Mass. (US) | ||
| Assigned to Vertex Pharmaceuticals Incorporated, Cambridge, Mass. (US) | ||
| Filed on Mar. 30, 2005, as Appl. No. 11/93,821. | ||
| Claims priority of provisional application 60/625599, filed on Nov. 05, 2004. | ||
| Claims priority of provisional application 60/557503, filed on Mar. 30, 2004. | ||
| Prior Publication US 2007/0043063 A1, Feb. 22, 2007 | ||
| Int. Cl. C07D 471/02 (2006.01) | ||
| U.S. Cl. 546—113 | 17 Claims |
1. A compound of formula (IB):
![]() R1 is hydrogen;
R2 and R4 are each hydrogen;
R3 is independently hydrogen or halogen;
x is 1, 2 or 3;
each occurrence of R5 is independently halogen, CN, NO2, or U—R′, wherein at least one R5 is other than H;
each U is independently a bond or an optionally substituted C1-C6 alkylidene chain, wherein up to two methylene units of the chain are optionally and independently replaced by —NR′—, —S—,
—O—, —CS—, —CO2—, —OCO—, —CO—, —CONR′—, —NR′CO—, —NR′CO2—, —SO2NR′—, —NR′SO2—, —CONR′NR′—, —NR′CONR′—, —OCONR′—, —NR′NR′—, —NR′SO2NR′—, —SO— or —SO2—; and
each occurrence of R′ is independently hydrogen or an optionally substituted group selected from a C1-C6 aliphatic group, a 3-8-membered saturated, partially unsaturated, or fully unsaturated monocyclic ring having 0-3 heteroatoms
independently selected from nitrogen, oxygen, or sulfur, or an 8-12 membered saturated, partially unsaturated, or fully unsaturated
bicyclic ring system having 0-5 heteroatoms independently selected from nitrogen, oxygen, or sulfur; or two occurrences of
R′, are taken together with the atom(s) to which they are bound to form an optionally substituted 3-12 membered saturated,
partially unsaturated, or fully unsaturated monocyclic or bicyclic ring having 0-4 heteroatoms independently selected from
nitrogen, oxygen, or sulfur;
wherein an optional substituent on an unsaturated carbon atom of an aryl or heteroaryl group is selected from halogen; —Ro; —ORo; —SRo; phenyl (Ph) optionally substituted with Ro; —O(Ph) optionally substituted with Ro; —(CH2)1-2(Ph), optionally substituted with Ro; —CH═CH(Ph), optionally substituted with Ro; a 5-6 membered heteroaryl or heterocyclic ring optionally substituted with Ro; —NO2; —CN; —N(Ro)2; —NRoC(O)Ro; —NRoC(S)Ro; —NRoC(O)N(Ro)2; —NRoC(S)N(Ro)2; —NRoCO2Ro; —NRoNRoC(O)Ro; —NRoNRoC(O)N(Ro)2; —NRoNRoCO2Ro; —C(O)CH2C(O)Ro; —CO2Ro; —C(O)Ro; —C(S)Ro; —C(O)N(Ro)2; —C(S)N(Ro)2; —OC(O)N(Ro)2; —OC(O)Ro; —C(O)N(ORo)Ro; —C(NORo)Ro; —S(O)2Ro; —S(O)3Ro; —SO2N(Ro)2; —S(O)Ro; —NRoSO2N(Ro)2; —NRoSO2Ro; —N(ORo)Ro; —C(═NH)—N(Ro)2; or —(CH2)0-2NHC(O)Ro; wherein each independent occurrence of Ro is selected from hydrogen, optionally substituted C1-6 aliphatic, an unsubstituted 5-6 membered heteroaryl or heterocyclic ring, phenyl, —O(Ph), or —CH2(Ph), or, two independent occurrences of Ro, on the same substituent or different substituents, taken together with the atom(s) to which each Ro group is bound, to form an optionally substituted 3-12 membered saturated, partially unsaturated, or fully unsaturated monocyclic
or bicyclic ring having 0-4 heteroatoms independently selected from nitrogen, oxygen, or sulfur; wherein each optional substituent
on the aliphatic group of Ro is selected from NH2, NH(C1-4 aliphatic), N(C1-4 aliphatic)2, halogen, C1-4 aliphatic, OH, O(C1-4 aliphatic), NO2, CN, CO2H, CO2(C1-4 aliphatic), O(haloC1-4 aliphatic), or haloC1-4 aliphatic, wherein each of the foregoing C1-4aliphatic groups of Ro is unsubstituted;
wherein an optional substituent on a saturated carbon of an aliphatic or heteroaliphatic group, or on a saturated carbon of
a non-aromatic heterocyclic ring is selected from halogen; —Ro; —ORo; —SRo; phenyl (Ph) optionally substituted with Ro; —O(Ph) optionally substituted with Ro; —(CH2)1-2(Ph), optionally substituted with Ro; —CH═CH(Ph), optionally substituted with Ro; a 5-6 membered heteroaryl or heterocyclic ring optionally substituted with Ro; —NO2; —CN; —N(Ro)2; —NRoC(O)Ro; —NRoC(S)Ro; —NRoC(O)N(Ro)2; —NRoC(S)N(Ro)2; —NRoCO2Ro; —NRoNRoC(O)Ro; —NRoNRoC(O)N(Ro)2; —NRoNRoCO2Ro; —C(O)CH2C(O)Ro; —CO2Ro; —C(O)Ro; —C(S)Ro; —C(O)N(Ro)2; —C(S)N(Ro)2; —OC(O)N(Ro)2; —OC(O)Ro; —C(O)N(ORo)Ro; —C(NORo)Ro; —S(O)2Ro; —S(O)3Ro; —SO2N(Ro)2; —S(O)Ro; —NRoSO2N(Ro)2; —NRoSO2Ro; —N(ORo)Ro; —C(═NH)—N(Ro)2; or —(CH2)0-2NHC(O)Ro; ═O; ═S; ═NNHR*; ═NN(R*)2; ═NNHC(O)R*; ═NNHCO2(alkyl); ═NNHSO2(alkyl); or ═NR*; where each R* is independently selected from hydrogen or a C1-6 aliphatic group;
wherein an optional substituent on a nitrogen of a non-aromatic heterocyclic ring is selected from —R+, —N(R+)2, —C(O)R+, —CO2R+, —C(O)CH2C(O)R+, —SO2R+, —SO2N(R+)2, —C(═S)N(R+1)2, —C(═NH)—N(R+)2, or —NR+SO2R+; wherein R+ is hydrogen, an optionally substituted C1-6 aliphatic, optionally substituted phenyl, optionally substituted —O(Ph), optionally substituted —CH2(Ph), optionally substituted —(CH2)1-2(Ph); optionally substituted —CH═CH(Ph); or an unsubstituted 5-6 membered heteroaryl or heterocyclic ring having one to four
heteroatoms independently selected from oxygen, nitrogen, or sulfur; or, two independent occurrences of R+, on the same substituent or different substituents, taken together with the atom(s) to which each R+ group is bound, form an optionally substituted 3-12 membered saturated, partially unsaturated, or fully unsaturated monocyclic
or bicyclic ring having 0-4 heteroatoms independently selected from nitrogen, oxygen, or sulfur; wherein an optional substituent
on the aliphatic group or the phenyl ring of R+ is selected from —NH2, —NH(C1-4 aliphatic), —N(C1-4 aliphatic)2, halogen, C1-4 aliphatic, —OH, —O(C1-4 aliphatic), —NO2, —CN, —CO2H, —CO2(C1-4 aliphatic), —O(halo C1-4 aliphatic), or halo(C1-4 aliphatic), wherein each of the foregoing C1-4aliphatic groups of R+ is unsubstituted;
provided that:
if R3 is H and x is 1, then R5 is not —SMe, NH2 or an optionally substituted NH-piperidine.
|